The DOI matches its Crossref record; 78 of the 81 references it cites were found in a registry or an index.
Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Open accessAbstract
Migraine is a disorder characterized by attacks of monolateral headaches, often accompanied by nausea, vomiting, and photophobia. Around 30% of patients also report aura symptoms. The cause of the aura is believed to be related to the cortical spreading depression (CSD), a wave of neuronal and glial depolarization originating in the occipital cortex, followed by temporary neuronal silencing. During a migraine attack, increased expression of inflammatory mediators, along with a decrease in the expression of anti-inflammatory genes, have been observed. The aim of this study was to evaluate the expression of inflammatory genes, in particular that of IL-1 receptor antagonist (IL-1RN), following CSD in a mouse model of familial hemiplegic migraine type 1 (FHM-1). We show here that the expression of IL-1RN was upregulated after the CSD, suggesting a possible attempt to modulate the inflammatory response. This study allows researchers to better understand the development of the disease and aids in the search for new therapeutic strategies in migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Receptor upregulation has been found in patients suffering from migraine with aura symptoms, believed to be associated with cortical spreading depression [55].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders, 3rd edition (beta version)
Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229
Interplay between Cortical Spreading Depolarization and Seizures
Kramer, D. R., Fujii, T., Ohiorhenuan, I., & Liu, C. Y. (2017) · Stereotactic and Functional Neurosurgery · doi:10.1159/000452841 · Cited by 3,696
The global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffman, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81373-2 · Cited by 2,339
Pathophysiology of the migraine aura: The spreading depression theory
Lauritzen, M. (1994) · Brain · doi:10.1093/brain/117.1.199 · Cited by 1,151 · cited 1×
“The cause of the aura is believed to be related to the cortical spreading depression (CSD), a self-propagating wave of cellular depolarization from the occipital cortex, followed by a transitory neuronal silencing [5,6].”
BackgroundINTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071 · cited 1×
“The protein encoded by IL-1RN is a soluble factor that regulates the inflammatory response, as reported by various studies [21,22,70,71].”
Noseda, R., & Burstein, R. (2013) · Pain · doi:10.1016/j.pain.2013.07.021 · Cited by 871
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Sex differences in the epidemiology, clinical features, and pathophysiology of migraine
Vetvik, K. G., & MacGregor, E. A. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30293-9 · Cited by 728
Research works printed but not linked: 1
- (2019, April 15). GEO DataSets, Available online: https://www.ncbi.nlm.nih.gov/gds.
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
“Receptor upregulation has been found in patients suffering from migraine with aura symptoms, believed to be associated with cortical spreading depression [55].”
BackgroundMigraine and neuroinflammation: the inflammasome perspective
Kursun, O., Yemisci, M., van den Maagdenberg, A. M. J. M., & Karatas, H. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01271-1 · Cited by 266
“in mouse model, in which the human FHM1 R192Q missense mutation was introduced [32], showed increased expression of IL-1 receptor antagonist (IL-1RN), and that expression of IL-6 was higher in the brains of FHM1 mutant mice compared to wild-type mice, whereas IL-2, IL-4, IL-10 and IL-13 did not reveal differential gen…”
BackgroundFagone, P., Ciurleo, R., Lombardo, S. D., Iacobello, C., Palermo, C. I., Shoenfeld, Y., Bendtzen, K., Bramanti, P., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102571 · Cited by 111
“The use of whole-genome expression data has been extensively used by ourselves and others for the identification of novel pathogenic pathways and therapeutic targets in several human pathologies including, autoimmune diseases [30–32] and cancer [33,34].”
Self-citationBiscetti, L., Cresta, E., Cupini, L. M., Calabresi, P., & Sarchielli, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106072 · Cited by 110
“…or the chemical stimulation of the dural receptive fields is an alternative strategy aimed at inducing both acute trigeminal fiber hypersensitivity as well as the activations of the TG, TNC and C1–C2 regions of the spinal cord (Burstein et al., 1998; Lukács et al., 2016; Lukács et al., 2015).”
BackgroundRole of Neuroinflammation and Blood-Brain Barrier Permutability on Migraine
Yamanaka, G., Suzuki, S., Morishita, N., Takeshita, M., Kanou, K., Takamatsu, T., Suzuki, S., Morıchı, S., Watanabe, Y., Ishida, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168929 · Cited by 77
“In addition to the experimental models described above, increased gene expressions of IL-1β and IL-1RA were also detected in a mouse model of FHM type 1 (FHM-1) [101,102].”
Method
Metadata
- Authors
- Lombardo, S., Mazzon, E., Basile, M., Cavalli, E., Bramanti, P., Nania, R., Fagone, P., Nicoletti, F., & Petralia, M.
- Affiliations
- University of Catania (IT)
- Centro Neurolesi Bonino Pulejo (IT)
- Corresponding author
- Nicoletti, Ferdinando
- ORCID
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2019-07-19
- Volume
- 9
- Issue
- 7
- Pages
- 172
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC6680509
- OpenAlex
- W2963510648
- Cited by
- 33
- References
- 81
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 11 · 2019: 7
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- IRCCS "Centro Neurolesi "Bonino Pulejo", Messina-Italy. (Current research funds 2018)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- migraine, interleukin-1 receptor antagonist, familial hemiplegic migraine type 1, cortical spreading depression, inflammation, inflammatory gene expression, mouse model, migraine aura
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine. https://app.cochat.ai/papers/10.3390/brainsci9070172
- The paper
- Lombardo, S., Mazzon, E., Basile, M., Cavalli, E., Bramanti, P., Nania, R., Fagone, P., Nicoletti, F., & Petralia, M. (2019). Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine. Brain Sciences. https://doi.org/10.3390/brainsci9070172
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.